In this sense, blocking JIP1-JNK could be an alternative to treat neurological diseases because even though knockout of JIP-1 did not affect APP transport or Aβ production [194], it interacts with the APP intracellular domain [195]. This evidence concerns the gene APP and nervous system disorder.